Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06726395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Name: Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia — clinical trial record (NCT06726395)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: COMeBAC

StatusRecruiting

PhasePhase 4

SponsorRegion Skane

Started2025-03-10

View on ClinicalTrials.gov ↗

Amendment history

2026-04-24

Study Status v2

Re-verified, no change to tracked fields

2025-03-10

Study Identification, Study Status, Contacts/Locations v1

Start dateestimated 2024-12→confirmed 2025-03-10

Study sitescontacts updated at 1 of 1 site

2024-12-05

Original filing

Region Skane

146 trials monitored

See 5 trials at risk

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Trial Details

NCT Number	NCT06726395
Lead Sponsor	Region Skane
Conditions	Staphylococcus Aureus Bacteraemia, Staphylococcal Bacteraemia, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia), Staphylococcus (S.) Aureus Infection
Enrollment	420 participants
Start Date	2025-03-10
Primary Completion	2028-04 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-04-30